Quote:

---

Imagine if AMBS were to run to a $1.00. Would you actually make the decision to hold for more? You’ve made 20 times what you can buy it for today, but you say to yourself, no I will wait to make 50 times my money. See how crazy that sounds?

---

If we get there it's a good problem to have and hard to make any type of decision right now. There will also be people that sit on the side line until it reaches .10, .50, .75 cents before they jump in so under your scenario, only the few that bought at a nickle would make 20 times if they cashed out at a buck.

ESS was tied up in a $1.643B lawsuit for years until Amarantus unraveled it, but there are folks that would like people to believe it's worthless. Regenicin, the previous owners, were valued at $1.8B before the litigation and a lot of positive events have happened since then. Get this into trial again and value will come back quickly as it's already been proven to work.